Department of Radiology, Children's Hospital of Philadelphia, 3401 Civic Center Boulevard, Philadelphia, PA, 19104, USA.
Department of Radiology and Medical Imaging, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Pediatr Radiol. 2024 Nov;54(12):1998-2005. doi: 10.1007/s00247-024-06052-x. Epub 2024 Sep 28.
Elevated spleen stiffness may be seen in patients with portal hypertension due to cirrhosis. In patients with Fontan physiology, elevated liver stiffness has been shown to correlate poorly with liver fibrosis. It is unknown whether spleen stiffness may instead serve as a surrogate marker of liver fibrosis in these patients.
To compare spleen stiffness determined by shear wave elastography (SWE) with histological findings of an ultrasound-guided liver biopsy in patients who had undergone Fontan palliation as a potential surrogate for Fontan-associated liver disease.
This was an IRB-approved single-center, retrospective study. Patients with Fontan palliation who had undergone both a spleen SWE study and a percutaneous liver biopsy between 2016 and 2020 were included. Biopsy, performed during cardiac catheterization, within 3 months of the SWE was required for inclusion. Using Kruskal-Wallis tests, spleen stiffness was compared with three liver biopsy scoring methods: Ishak, METAVIR, and congestive hepatic fibrosis score (CHFS). When available, Pearson's correlation was also used to compare collagen deposition determined using Sirius Red stain (%SR) with SWE values. A P-value < 0.05 was considered statistically significant.
Twenty-two patients (15 males) were included in the study, with a median age of 17 years (IQR is 14.8-20.5 years; age range: 7 years to 30.2 years). The median spleen stiffness was 2.94 m/s (IQR: 2.57-3.61 m/s; range: 1.48-4.27 m/s). The median Fontan pressure was 11 mm Hg (IQR: 10-13.3 mm Hg; range: 7-19 mm Hg) obtained within a median of 10 days (IQR: 1-41 days) of SWE. Splenic stiffness did not correlate with the extent of fibrosis determined by histology (all P > 0.05). There was also no statistically significant correlation between the %SR staining and SWE-determined spleen stiffness (Pearson's correlation of 0.165, P = 0.59, n = 13).
In this preliminary study, SWE spleen stiffness values did not correlate with biopsy-determined scoring of liver fibrosis in patients with Fontan physiology.
由于肝硬化,门静脉高压症患者的脾脏硬度可能会升高。在接受 Fontan 手术的患者中,已证明升高的肝硬度与肝纤维化相关性较差。尚不清楚脾脏硬度是否可以替代这些患者的肝纤维化的替代标志物。
通过剪切波弹性成像(SWE)比较接受 Fontan 姑息治疗的患者的脾脏硬度与超声引导下肝活检的组织学结果,以作为 Fontan 相关肝病的潜在替代标志物。
这是一项经机构审查委员会批准的单中心回顾性研究。纳入了 2016 年至 2020 年间接受脾脏 SWE 研究和经皮肝活检的接受 Fontan 姑息治疗的患者。需要在 SWE 后 3 个月内进行心脏导管插入术时进行活检。使用 Kruskal-Wallis 检验比较 Ishak、METAVIR 和充血性肝纤维化评分(CHFS)三种肝活检评分方法。在有条件的情况下,还使用 Pearson 相关分析比较天狼星红染色(%SR)确定的胶原蛋白沉积与 SWE 值之间的相关性。P 值<0.05 被认为具有统计学意义。
本研究纳入了 22 名患者(15 名男性),中位年龄为 17 岁(IQR 为 14.8-20.5 岁;年龄范围:7 岁至 30.2 岁)。脾脏硬度的中位数为 2.94m/s(IQR:2.57-3.61m/s;范围:1.48-4.27m/s)。中位 Fontan 压力为 11mmHg(IQR:10-13.3mmHg;范围:7-19mmHg),在 SWE 后中位时间 10 天(IQR:1-41 天)内获得。脾脏硬度与组织学确定的纤维化程度无相关性(均 P>0.05)。SWE 确定的脾脏硬度与 %SR 染色之间也没有统计学显著相关性(Pearson 相关系数为 0.165,P=0.59,n=13)。
在这项初步研究中,SWE 脾脏硬度值与接受 Fontan 手术的患者的活检确定的肝纤维化评分无相关性。